Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, April 28, 2014, 67 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $849.00 to $372,250,000.00.

Highlighted Stocks Traded by Insiders:

Cardiovascular Systems (CSII) - FREE Research Report

Kenny Kevin J, who is Exec. VP, Sales & Mtkg at Cardiovascular Systems, sold 15,484 shares at $28.79 on April 28, 2014. Following this transaction, the Exec. VP, Sales & Mtkg owned 66,841 shares meaning that the stake was reduced by 18.81% with the 15,484-share transaction.

The shares most recently traded at $28.05, down $0.74, or 2.65% since the insider transaction. Historical insider transactions for Cardiovascular Systems go as follows:

  • 4-Week # shares sold: 3,500
  • 12-Week # shares sold: 20,279
  • 24-Week # shares bought: 10,250
  • 24-Week # shares sold: 31,637

The average volume for Cardiovascular Systems has been 307,300 shares per day over the past 30 days. Cardiovascular Systems has a market cap of $862.0 million and is part of the health care sector and health services industry. Shares are down 18.29% year-to-date as of the close of trading on Monday.

Cardiovascular Systems, Inc., a medical device company, focuses on developing and commercializing minimally invasive treatment solutions for vascular diseases. Currently, there are 6 analysts who rate Cardiovascular Systems a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CSII - FREE

TheStreet Quant Ratings

rates Cardiovascular Systems as a

sell

. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, deteriorating net income and weak operating cash flow. Get the full

Cardiovascular Systems Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Penske Automotive Group (PAG) - FREE Research Report

Barr John, who is Director at Penske Automotive Group, sold 10,000 shares at $44.50 on April 28, 2014. Following this transaction, the Director owned 7,000 shares meaning that the stake was reduced by 58.82% with the 10,000-share transaction.

The shares most recently traded at $45.01, up $0.51, or 1.13% since the insider transaction. Historical insider transactions for Penske Automotive Group go as follows:

  • 12-Week # shares sold: 234,452
  • 24-Week # shares sold: 234,452

The average volume for Penske Automotive Group has been 258,900 shares per day over the past 30 days. Penske Automotive Group has a market cap of $4.1 billion and is part of the services sector and specialty retail industry. Shares are down 6.64% year-to-date as of the close of trading on Friday.

Penske Automotive Group, Inc. operates as an automotive retailer. The company operates through two segments, Retail and Other. It sells new and used motor vehicles of approximately 35 brands. The stock currently has a dividend yield of 1.6%. The company has a P/E ratio of 16.2. Currently, there are 6 analysts who rate Penske Automotive Group a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on PAG - FREE

TheStreet Quant Ratings

rates Penske Automotive Group as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, impressive record of earnings per share growth, compelling growth in net income and attractive valuation levels. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full

Penske Automotive Group Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Coca-Cola (CCE) - FREE Research Report

Johnson Thomas H, who is Director at Coca-Cola, sold 3,500 shares at $46.34 on April 28, 2014. Following this transaction, the Director owned 13,000 shares meaning that the stake was reduced by 21.21% with the 3,500-share transaction.

The shares most recently traded at $45.55, down $0.79, or 1.73% since the insider transaction.

The average volume for Coca-Cola has been 2.3 million shares per day over the past 30 days. Coca-Cola has a market cap of $11.6 billion and is part of the consumer goods sector and food & beverage industry. Shares are up 4.17% year-to-date as of the close of trading on Monday.

Coca-Cola Enterprises, Inc. produces, distributes, and markets nonalcoholic beverages. It provides still and sparkling waters, flavored waters, juice and juice drinks, sports drinks, energy drinks, teas, and coffees. The stock currently has a dividend yield of 2.1%. The company has a P/E ratio of 19.5. Currently, there are 3 analysts who rate Coca-Cola a buy, 1 analyst rates it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CCE - FREE

TheStreet Quant Ratings

rates Coca-Cola as a

buy

. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, increase in net income, revenue growth and notable return on equity. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full

Coca-Cola Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null